But one of the other things that I think—and we're not going to be able to do it in the time that requires us to make lawful the question that the High Court has determined, but I read with interest in the judgment that Pfizer were asked by the ministry, in addition to their provisional consent, to actually table a full consent under section 20 or 21. Now, that raises the perception, and clearly the authorities believed that a provisional consent wasn't sufficient to satisfy all of the questions that it had regarding—certainly—efficacy, because, of course, with the vaccine roll-out, one wouldn't know the efficacy of the vaccine until the end of the product. But it also talked in the court judgment that Pfizer were also asked to continue to provide other information, including that around safety. Now, this raises an interesting question of the degree to which the lifting of the limit on the number of people, the class of people that could benefit from a new medicine, is then going to mean that any vaccine may never get full consent under section 21, because we now know the seasonal influenza vaccine has probably been captured by the court judgment. 